Maneesh Bhargava, MBBS

Maneesh Bhargava practices at OSU Internal Medicine in Columbus, Ohio.

Maneesh Bhargava's NPI, 1407892755, was assigned on June 22, 2006. Maneesh Bhargava holds Ohio license 35.151735.

Maneesh Bhargava's primary practice is OSU Internal Medicine, at 2050 Kenny Rd, Columbus, OH 43221 in Franklin County. The practice phone is (614) 293-2229.

Maneesh Bhargava's primary practice is OSU Internal Medicine in Columbus, Ohio. Maneesh Bhargava is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Maneesh Bhargava to 1 more hospital, 5 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Maneesh Bhargava practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Maneesh Bhargava's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Maneesh Bhargava's licenses on file in 2 states: Ohio and Minnesota.

CMS data shows 45 Medicare services from Maneesh Bhargava across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $1,527 for them.

CMS counts 50 Medicare patients who saw Maneesh Bhargava in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 26% are also on Medicaid. Their average risk score is 3.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Maneesh Bhargava's median patient age at 64, with 48% women.

In 2024, Maneesh Bhargava wrote 258 Medicare Part D claims for 34 patients. 60% of them were for generic drugs. CMS names the drug for 157 of them, across 8 drugs with 11 or more claims each, at $131,421 in total drug cost. In 2023, CMS named 173 claims across 9 drugs.

Maneesh Bhargava accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Maneesh Bhargava as offering telehealth.

Dmand AI links 41 papers to Maneesh Bhargava, published from 2011 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Sarcoidosis, Phenotype and Bronchoalveolar Lavage Fluid. Maneesh Bhargava has published most often in Am J Respir Cell Mol Biol. Maneesh Bhargava's most frequent co-authors are David Morris Perlman, MD, Jeremy Scott Markowitz, MD and Henri Roukoz, MD.

CMS Open Payments shows 4 general payments to Maneesh Bhargava from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $272.